Evidence map›Paper›PMID 22117825›Full record

ArticleBosnian journal of basic medical sciences2011

The hepatic protective mechanism of Ginkgo biloba extract in rats with obstructive jaundice.

Ming-Zhe Weng, Xian-Ping Zhou, Jian-Guang Jia, Jing Ding, Cui-Fu Fang, Yi-Yu Qin, Shao-Fu Tao, Long-Hua Rao, Ji-Yu Li, Zhi-Wei Quan

Open access · diamondAbstract read
In one paragraph

Article in Bosnian journal of basic medical sciences, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Evidence-based complementary and alternative medicine : eCAM · 2022
    Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ming-Zhe WengDepartment of General Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, China.
Xian-Ping Zhou
Jian-Guang Jia
Jing Ding
Cui-Fu Fang
Yi-Yu Qin
Shao-Fu Tao
Long-Hua Rao
Ji-Yu Li
Zhi-Wei Quan
XinHua Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of our study was to examine the hepatic protective mechanism of Ginkgo biloba extract (GBE) in rats with obstructive jaundice (OJ). Twenty rats underwent bile duct ligation and received daily intraperitoneal injections of either control saline or Ginkgo biloba extract for 14 days. Ten sham-operated rats had their bile duct exposed but not ligated or sectioned. Serum alanine transaminase (ALT) was analyzed for liver function tests and liver damage was further assessed by histologic examination. The levels of endothelin 1 (ET-1) and nitric oxide (NO) in blood and liver homogenate were measured. The serum alanine transaminase was elevated in the bile duct ligation rats (BDL rats); GBE could significantly lower serum transaminase level and ameliorate liver histological damage. ET-1 and NO levels in both plasma and liver tissue were also elevated in common bile duct (CBD)-ligated rats, but this increase was significantly decreased by GBE treatment. Moreover, the degree of liver damage severity positively correlates with high levels of ET-1 and NO. GBE mediated the liver protective effect at least in part by suppressing overproduction of ET-1 and NO and restoring a proper balance between ET-1 and NO to some extent.

Indexed as

Ginkgo bilobaAlanine TransaminaseAnimalsDisease Models, AnimalEndothelin-1FemaleJaundice, ObstructiveLiverMaleNitric OxidePlant ExtractsRatsRats, WistarAlanine TransaminaseEndothelin-1Nitric OxidePlant Extracts

Identifiers

PMID22117825
PMCPMC4362573
OpenAlexW2189145389

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.